Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
LIGAND PHARMACEUTICALS INC (LGND)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-05-17 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 6.1 | 1.8 | 1.4 | 2.3 | 2.7 | | 3.9 | |
Asset turnover | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | | 0.2 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -0.1% | 20.3% | 1.0% | 67.4% | 24.4% | | 3.6% | |
ROIC (including intangibles) | -0.1% | 7.7% | 0.6% | 45.2% | 12.4% | | 2.3% | |
ROE | -0.1% | 11.6% | 1.0% | 83.1% | 24.1% | | 3.6% | |
ROA | -0.1% | 7.3% | 0.5% | 42.6% | 10.7% | | 2.2% | |
|
Cash Conversion Cycle |
Days sales outstanding | 56.6 | 112.5 | 111.3 | 92.2 | 81.1 | | 66.2 | |
Days payables outstanding | | 65.0 | 58.9 | 52.4 | 96.7 | | 68.0 | |
Days inventory outstanding | 39.4 | 211.5 | 412.4 | 157.9 | 164.7 | | 131.7 | |
Cash conversion cycle | 96.0 | 259.0 | 464.8 | 197.7 | 149.0 | | 129.9 | |
|